Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression

详细信息    查看全文

• 作者：Gang Cheng (1)
  Leiming Zhang (1)
  Wenying Lv (1)
  Chao Dong (1)
  Yaming Wang (1)
  Jianning Zhang (1)
  
• 关键词：Meningioma ; Cyclin D1 ; Invasion ; Apoptosis ; Recurrence
• 刊名：Medical Oncology
• 出版年：2015
• 出版时间：January 2015
• 年：2015
• 卷：32
• 期：1
• 全文大小：4,145 KB
• 参考文献：1. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996;29(3):197鈥?05. CrossRef
  2. Shetty R, Sharma RM, Pandey P. Diaphragma sella meningioma presenting with posterior cerebral artery infarct: case report and review of literature. Neurol India. 2014;62(1):77鈥?. CrossRef
  3. Maier H, et al. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg. 1992;77(4):616鈥?3. CrossRef
  4. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007;98(5):629鈥?5. CrossRef
  5. Liao D, et al. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case鈥揷ontrol study and meta-analysis. PLoS ONE. 2014;9(11):e113299. CrossRef
  6. Li X, et al. Genetic association between cyclin D1 polymorphism and breast cancer susceptibility. Tumour Biol. 2014. doi:10.1007/s13277-014-2489-5 .
  7. Wang J, et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol. 2012;106(3):473鈥?4. CrossRef
  8. Baldin V, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7(5):812鈥?1. CrossRef
  9. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 2001;411(6841):1017鈥?1. CrossRef
  10. Gao P, et al. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. World J Gastroenterol. 2004;10(20):2936鈥?.
  11. Ravikumar G, Ananthamurthy A. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters. J Cancer Res Ther. 2014;10(3):671鈥?.
  12. Toyoda H, et al. Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors. Dig Dis Sci. 2000;45(5):864鈥?. CrossRef
  13. Bahnassy AA, et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 2004;4:22. CrossRef
  14. Cakina S, et al. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer. Indian J Biochem Biophys. 2013;50(3):233鈥?.
  15. Zhou P, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene. 1995;11(3):571鈥?0.
  16. Jiang W, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene. 1993;8(12):3447鈥?7.
  17. Wang Q, et al. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Carcinogenesis. 2013;34(4):916鈥?6. CrossRef
  18. Wang Q, et al. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells. J Neurooncol. 2013;112(1):73鈥?2. CrossRef
  19. Barresi V, et al. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk? J Neurooncol. 2011;102(2):189鈥?6. CrossRef
  20. Tummalapalli P, et al. RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. Int J Oncol. 2007;31(5):1039鈥?0.
  21. Okada M, et al. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol. 2004;66(1鈥?):29鈥?7. CrossRef
  22. Nordqvist AC, Smurawa H, Mathiesen T. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg. 2001;95(5):839鈥?4. CrossRef
  23. Uren AG, et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol. 2000;10(21):1319鈥?8. CrossRef
  24. Grossman D, et al. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA. 2001;98(2):635鈥?0. CrossRef
  25. Olie RA, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 2000;60(11):2805鈥?.
  26. Ai Z, et al. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 2006;107(4):746鈥?6. CrossRef
  27. Koehler BC, et al. Beyond cell death鈥攁ntiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro. PLoS ONE. 2013;8(10):e76446. CrossRef
  28. Hassankhani R, et al. Prodigiosin isolated from cell wall of / Serratia marcescens alters expression of apoptosis-related genes and increases apoptosis in colorectal cancer cells. Med Oncol. 2015;32(1):366. CrossRef
  
• 作者单位：Gang Cheng (1)
  Leiming Zhang (1)
  Wenying Lv (1)
  Chao Dong (1)
  Yaming Wang (1)
  Jianning Zhang (1)
  
  1. Department of Neurosurgery, Navy General Hospital of PLA, 6 Fucheng Road, Haidian District, Beijing, 100048, China
  
• ISSN：1559-131X

文摘

Cyclin D1 has been reported overexpressed in many malignant cancers. However, the expression pattern and biological function of cyclin D1 in meningiomas are still unknown. In this study, we examined the expression of cyclin D1 in meningioma with immunohistochemistry and correlated the measure to the recurrence. Potential effects of cyclin D1 on tumor growth and apoptosis were also examined in representative cell lines (IOMM-Lee and CH157) by inhibiting cyclin D1 with RNA interference. We demonstrate that cyclin D1 mRNA and protein expression are positively correlated with meningioma grade and that higher cyclin D1 expression correlates with higher recurrence. Knockdown of cyclin D1 by the siRNA decreased IOMM-Lee and CH157 cell proliferation, promoted the rate of apoptosis and attenuated invasive capacity. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and Western blot analysis revealed that cells stably underexpressing cyclin D1 showed lower expression of survivin and the antiapoptotic protein B cell lymphoma-2 (Bcl-2) compared to control cells. These results indicate that high cyclin D1 expression is associated with a poor outcome of meningioma patients and knockdown of cyclin D1 expression may be a potential treatment for malignant meningioma.